Qiaoying Hu

439 total citations
27 papers, 311 citations indexed

About

Qiaoying Hu is a scholar working on Otorhinolaryngology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qiaoying Hu has authored 27 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Otorhinolaryngology, 12 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qiaoying Hu's work include Head and Neck Cancer Studies (18 papers), Head and Neck Surgical Oncology (10 papers) and Brain Metastases and Treatment (5 papers). Qiaoying Hu is often cited by papers focused on Head and Neck Cancer Studies (18 papers), Head and Neck Surgical Oncology (10 papers) and Brain Metastases and Treatment (5 papers). Qiaoying Hu collaborates with scholars based in China. Qiaoying Hu's co-authors include Xiaozhong Chen, Caineng Cao, Yongfeng Piao, Lei Wang, Qiu Tang, Yanru Feng, Shenglin Ma, Yuanyuan Chen, Feng Jiang and Shuang Huang and has published in prestigious journals such as Scientific Reports, BioMed Research International and Cancer Science.

In The Last Decade

Qiaoying Hu

25 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiaoying Hu China 12 162 100 86 75 72 27 311
Haijun Wu China 8 101 0.6× 66 0.7× 39 0.5× 70 0.9× 141 2.0× 16 300
C. El Khoury France 9 81 0.5× 71 0.7× 54 0.6× 128 1.7× 56 0.8× 28 330
Hetty Mast Netherlands 11 210 1.3× 150 1.5× 92 1.1× 48 0.6× 95 1.3× 30 369
Dian Ouyang China 10 117 0.7× 85 0.8× 41 0.5× 123 1.6× 113 1.6× 19 358
Jianhui Ding China 10 142 0.9× 146 1.5× 148 1.7× 93 1.2× 83 1.2× 17 307
Wai Kuen Kan China 4 295 1.8× 180 1.8× 110 1.3× 77 1.0× 131 1.8× 8 387
Thomas J.W. Klein Nulent Netherlands 8 144 0.9× 202 2.0× 114 1.3× 131 1.7× 112 1.6× 11 398
Nachi Palaniappan United Kingdom 8 218 1.3× 171 1.7× 87 1.0× 32 0.4× 73 1.0× 16 314
W. Chris Sheils United States 5 150 0.9× 102 1.0× 119 1.4× 47 0.6× 79 1.1× 6 298
Koichi Morimoto Japan 8 131 0.8× 170 1.7× 105 1.2× 53 0.7× 81 1.1× 21 359

Countries citing papers authored by Qiaoying Hu

Since Specialization
Citations

This map shows the geographic impact of Qiaoying Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiaoying Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiaoying Hu more than expected).

Fields of papers citing papers by Qiaoying Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiaoying Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiaoying Hu. The network helps show where Qiaoying Hu may publish in the future.

Co-authorship network of co-authors of Qiaoying Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Qiaoying Hu. A scholar is included among the top collaborators of Qiaoying Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiaoying Hu. Qiaoying Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Le, Feng Jiang, Qifeng Jin, et al.. (2025). Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastoma. Neoplasia. 63. 101156–101156.
2.
Fang, Yuting, Feng Jiang, Qifeng Jin, et al.. (2024). Concurrent nimotuzumab and intensity‐modulated radiotherapy for elderly patients with locally advanced nasopharyngeal carcinoma. Cancer Science. 115(8). 2729–2737. 1 indexed citations
3.
Piao, Yongfeng, Caineng Cao, Shuang Huang, et al.. (2021). Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR. European Archives of Oto-Rhino-Laryngology. 279(1). 353–359. 12 indexed citations
4.
Cao, Caineng, Shuang Huang, Feng Jiang, et al.. (2021). Locoregional Extension Patterns of Nasopharyngeal Carcinoma Detected by FDG PET/MR. Frontiers in Oncology. 11. 763114–763114. 15 indexed citations
5.
Liu, Tongxin, et al.. (2020). <p>Outcome and Optimal Treatment for Esthesioneuroblastoma in the Era of Intensity-Modulated Radiation Therapy: A Single-Center Experience</p>. Cancer Management and Research. Volume 12. 8355–8362. 2 indexed citations
6.
7.
Tao, Changjuan, Peng Zhang, Ling Zhou, Qiaoying Hu, & Xiaozhong Chen. (2020). Apatinib in treating patients with recurrent or metastatic nasopharyngeal carcinoma who had failed prior platinum-based chemotherapy. Translational Cancer Research. 9(10). 6392–6401. 3 indexed citations
8.
Feng, Yanru, Caineng Cao, Qiaoying Hu, & Xiaozhong Chen. (2019). Grading of MRI–detected skull-base invasion in nasopharyngeal carcinoma with skull-base invasion after intensity-modulated radiotherapy. Radiation Oncology. 14(1). 10–10. 13 indexed citations
9.
Cao, Caineng, et al.. (2019). Feasibility of multiparametric imaging with PET/MR in nasopharyngeal carcinoma: A pilot study. Oral Oncology. 93. 91–95. 14 indexed citations
10.
Chen, Yuanyuan, Shuang Huang, Qiaoying Hu, et al.. (2019). Effects of oral nutritional supplement on short-term nutritional status and treatment tolerance in locally advanced nasopharyngeal carcinoma patients receiving chemoradiotherapy. Zhonghua fangshe zhongliuxue zazhi. 28(8). 575–579. 1 indexed citations
11.
Cao, Caineng, Qichun Wei, Xiuwen Tang, et al.. (2018). PD‐1 and PD‐L1 in locoregionally advanced nasopharyngeal carcinoma: Substudy of a randomized phase III trial. Head & Neck. 41(5). 1427–1433. 15 indexed citations
12.
Kong, Yue, Lei Shi, Shuang Huang, et al.. (2018). Analysis of memory function and MRI changes in nasopharyngeal carcinoma patients after radiotherapy. Zhonghua fangshe yixue yu fanghu zazhi. 38(2). 105–109. 1 indexed citations
13.
Cao, Caineng, Feng Jiang, Qifeng Jin, et al.. (2018). Locoregional extension and patterns of failure for nasopharyngeal carcinoma with intracranial extension. Oral Oncology. 79. 27–32. 20 indexed citations
14.
Feng, Yanru, Caineng Cao, Qiaoying Hu, & Xiaozhong Chen. (2018). Prognostic Value and Staging Classification of Lymph Nodal Necrosis in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy. Cancer Research and Treatment. 51(3). 1222–1230. 27 indexed citations
15.
Shi, Lei, Qinglin Li, Yue Kong, et al.. (2018). Results of the radiation dose of head, body and tail of hippocampus in nasopharyngeal carcinoma patients treated with intensity modulated radiotherapy. Scientific Reports. 8(1). 5595–5595. 6 indexed citations
16.
Cao, Caineng, Qiaoying Hu, & Xiaozhong Chen. (2017). Intensity‐modulated radiotherapy for elderly patients with nasopharyngeal carcinoma. Head & Neck. 40(3). 590–595. 11 indexed citations
17.
Tang, Qiu, et al.. (2016). Correlation between pretreatment serum LDL-cholesterol levels and prognosis in nasopharyngeal carcinoma patients. OncoTargets and Therapy. 9. 2585–2585. 11 indexed citations
18.
19.
Hu, Qiaoying, et al.. (2015). Effect of capilliposide for induction apoptosis in human nasopharyngeal cancer CNE-2 cells through up-regulating PUMA expression. Journal of Cancer Research and Therapeutics. 11(8). 239–239. 4 indexed citations
20.
Hu, Qiaoying, et al.. (2013). Effect of number and ratio of positive lymph nodes in hypopharyngeal cancer. Head & Neck. 37(1). 111–116. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haijun Wu Breakdown of academic impact, for papers by C. El Khoury Breakdown of academic impact, for papers by Hetty Mast Breakdown of academic impact, for papers by Dian Ouyang Breakdown of academic impact, for papers by Jianhui Ding Breakdown of academic impact, for papers by Wai Kuen Kan Breakdown of academic impact, for papers by Thomas J.W. Klein Nulent Breakdown of academic impact, for papers by Nachi Palaniappan Breakdown of academic impact, for papers by W. Chris Sheils Breakdown of academic impact, for papers by Koichi Morimoto
Rankless by CCL
2026